✦ LIBER ✦

A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer

✍ Scribed by Matthew G. Fury; Sofia Haque; Hilda Stambuk; Ronglai Shen; Diane Carlson; David Pfister

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of Gemcitabine in Patients wi

✍ Wolfram E. Samlowski; Holly Gundacker; J. Philip Kuebler; Jeffrey K. Giguere; Gl 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 68 KB

Phase II study of paclitaxel, ifosfamide

✍ Dong M. Shin; Fadlo R. Khuri; Bonnie S. Glisson; Lawrence Ginsberg; Vali M. Papa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Promising overall survival of patients w

✍ Muh-Hwa Yang; Peter Mu-Hsin Chang; Cheng-Hwai Tzeng; Shyue-Yih Chang; Pen-Yuan C 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 324 KB

Phase II trial of irinotecan plus cispla

✍ Jill Gilbert; Anthony Cmelak; Yu Shyr; James Netterville; Brian B. Burkey; Rober 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

A phase II study of sunitinib in patient

✍ George Fountzilas; Anna Fragkoulidi; Anna Kalogera-Fountzila; Martha Nikolaidou; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 639 KB

A Phase II Trial of Bryostatin-1 in Pati

✍ David G. Pfister; John McCaffrey; Andrew J. Zahalsky; Gary K. Schwartz; Eric Lis 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 77 KB